Cholesterol synthesis inhibition elicits an integrated molecular response in human livers including decreased ACAT2.
Parini P, Gustafsson U, Davis MA, Larsson L, Einarsson C, Wilson M, Rudling M, Tomoda H, Omura S, Sahlin S, Angelin B, Rudel LL, Eriksson M.
Parini P, et al. Among authors: sahlin s.
Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1200-6. doi: 10.1161/ATVBAHA.107.157172. Epub 2008 Mar 13.
Arterioscler Thromb Vasc Biol. 2008.
PMID: 18340009
Free PMC article.
Clinical Trial.